Stocktoria

BIO-RAD LABORATORIES, INC. BIO

NYSE · stock · Laboratory Analytical Instruments · website · IPO 1980-03-17 · LEI

BIO-RAD LABORATORIES, INC. statistics & valuation

Market cap$8.1B
P / E10.7×
P / S3.1×
P / B1.1×
P / FCF21.7×
Net margin29.4%
Return on equity10.2%
FCF margin14.5%
Net debt$673.2M
Net debt / EBITDA3.2×
Enterprise value USD$8.8B
EV / EBITDA41.3×
Earnings yield EBIT/EV0.5%
Return on capital0.5%
Graham number +14.3%$413.77

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($413.77); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
1.30% 5.70% 16.00% 76.10% 149.80% 145.60% -129.50% -23.90% -71.90% 29.40% 2016201720182019202020212022202320242025
Gross margin (%)
55.00% 55.00% 53.40% 54.40% 56.50% 56.10% 55.90% 53.40% 53.70% 51.90% 2016201720182019202020212022202320242025
Operating margin (%)
2.70% 5.50% -4.50% 9.90% 16.60% 17.10% 17.20% 12.60% 10.50% 1.80% 2016201720182019202020212022202320242025
Return on equity (%)
1.00% 4.20% 9.10% 30.50% 38.60% 31.10% -37.70% -7.30% -28.10% 10.20% 2016201720182019202020212022202320242025
Shares outstanding
29.6M 30.0M 30.2M 30.2M 30.2M 30.2M 29.8M 29.2M 28.2M 27.3M 2016201720182019202020212022202320242025
Net debt ($)
$7.4M -$647.1M -$649.9M -$460.3M $763.5M $806.3M $712.3M $673.2M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
0.70% 2.90% 6.50% 22.00% 29.40% 23.90% -26.90% -5.20% -19.70% 7.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
3.60% -0.30% 6.80% 15.50% 18.70% 18.30% 2.90% 8.20% 11.30% 14.50% 2016201720182019202020212022202320242025
Debt / equity (×)
0.11× 0.00× 0.00× 0.00× 0.12× 0.14× 0.18× 0.16× 2016201720182019202020212022202320242025
EPS ($)
$0.88 $4.07 $12.10 $58.27 $126.47 $140.83 -$121.79 -$21.82 -$65.36 $27.85 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

BIO-RAD LABORATORIES, INC. trades at about 13× earnings — below its 10-year norm (10-year range 4.3×–216×, median 34.4×).

4.3× 216×

Shaded band = 10-year range (4.3×–216×); dot = today's 13×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin51.9%53.7%53.4%55.9%56.1%56.5%54.4%53.4%55.0%55.0%
Operating margin1.8%10.5%12.6%17.2%17.1%16.6%9.9%-4.5%5.5%2.7%
Net margin29.4%-71.9%-23.9%-129.5%145.6%149.8%76.1%16.0%5.7%1.3%
FCF margin14.5%11.3%8.2%2.9%18.3%18.7%15.5%6.8%-0.3%3.6%
Return on assets7.2%-19.7%-5.2%-26.9%23.9%29.4%22.0%6.5%2.9%0.7%
Return on equity10.2%-28.1%-7.3%-37.7%31.1%38.6%30.5%9.1%4.2%1.0%
Debt / equity0.16×0.18×0.14×0.12×0.00×0.00×0.00×0.11×——
Current ratio5.626.485.835.552.923.392.414.493.933.91

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.